Compliance and patching and atropine amblyopia treatments
dc.contributor.author | Wang, Jingyun | |
dc.contributor.department | Department of Ophthalmology, IU School of Medicine | en_US |
dc.date.accessioned | 2016-05-05T17:01:37Z | |
dc.date.available | 2016-05-05T17:01:37Z | |
dc.date.issued | 2015-09 | |
dc.description.abstract | In the past 20 years, there has been a great advancement in knowledge pertaining to compliance with amblyopia treatments. The occlusion dose monitor introduced quantitative monitoring methods in patching, which sparked our initial understanding of the dose–response relationship for patching amblyopia treatment. This review focuses on current compliance knowledge and the impact it has on patching and atropine amblyopia treatment. | en_US |
dc.eprint.version | Final published version | en_US |
dc.identifier.citation | Wang, J. (2015). Compliance and patching and atropine amblyopia treatments. Vision research, 114, 31-40. | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/9528 | |
dc.language.iso | en | en_US |
dc.publisher | Elsevier | en_US |
dc.relation.isversionof | 10.1016/j.visres.2015.02.012 | en_US |
dc.relation.journal | Vision Research | en_US |
dc.rights | Publisher Policy | en_US |
dc.source | Author | en_US |
dc.subject | amblyopia | en_US |
dc.subject | compliance | en_US |
dc.subject | occlusion | en_US |
dc.title | Compliance and patching and atropine amblyopia treatments | en_US |
dc.type | Article | en_US |